Gi Cancers clinical trials

Explore recruiting gi cancers clinical trials.

Recruiting gi cancers studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Gi Cancers trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

AN OPEN-LABEL, SINGLE-ARM, PHASE IB/IIA TRIAL TO EVALUATE THE SAFETY AND EFFICACY OF THE EP4 RECEPTOR ANTAGONIST VORBIPIPRANT (CR6086) IN COMBINATION WITH THE PD-1 INHIBITOR BALSTILIMAB (AGEN2034), IN PATIENTS WITH PRETREATED MISMATCH-REPAIR-PROFICIENT AND MICROSATELLITE STABLE METASTATIC COLORECTAL CANCER, AND OTHER METASTATIC GI CANCERS.

Italy

Phase I and Phase II (Integrated)- Other EU CTIS Study details

Gi Cancers trials by city

Gi Cancers in Toronto Gi Cancers in Vancouver Gi Cancers in Montreal Gi Cancers in Calgary Gi Cancers in Edmonton Gi Cancers in Ottawa Gi Cancers in Winnipeg Gi Cancers in Quebec City Gi Cancers in Hamilton Gi Cancers in Kitchener Gi Cancers in London Gi Cancers in Halifax Gi Cancers in New York Gi Cancers in Los Angeles Gi Cancers in Chicago Gi Cancers in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease